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to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site
Abstract
The hypoxia-inducible factor-1 (HIF-1) was first described as a DNA binding activity that specifically
recognizes an 8 bp motif known to be essential for hypoxia-inducible erythropoietin gene transcription.
Subsequently HIF-1 activity has also been found in cell lines which do not express erythropoietin,
suggesting that HIF-1 is part of a widespread oxygen sensing mechanism. In electrophoretic mobility
shift assays HIF-1 DNA binding activity is only detectable in nuclear extracts of cells cultivated in a low
oxygen atmosphere. In addition to HIF-1, a constitutive DNA binding activity also specifically binds the
HIF1 probe. Here we report that CRE and AP1 oligonucleotides efficiently competed for binding of the
HIF1 probe to this constitutive factor, whereas HIF-1 activity itself remained unaffected. Monoclonal
antibodies raised against the CRE binding factors ATF-1 and CREB-1 supershifted the constitutive
factors ATF-1 and CREB-1 supershifted the constitutive factor, while Jun and Fos family members,
which constitute the AP-1 factor, were immunologically undetectable. Recombinant ATF-1 and
CREB-1 proteins bound HIF1 probes either as homodimers or as heterodimers, indicating a new binding
specificity for ATF-1/CREB-1. Finally, reporter gene assays in HeLa cells treated with either a cAMP
analogue or a phorbol ester suggest that the PKA, but not the PKC signalling pathway is involved in
oxygen sensing.
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ABSTRACT
The hypoxia-inducible factor-I (HIF-1) was first
described as a DNA binding activity that specifically
recognizes an 8 bp motif known to be essential for
hypoxia-inducible erythropoietin gene transcription.
Subsequently HIF-1 activity has also been found in cell
lines which do not express erythropoietin, suggesting
that HIF-1 is part of a widespread oxygen sensing
mechanism. In electrophoretic mobility shift assays
HIF-1 DNA binding activity is only detectable in nuclear
extracts of cells cultivated in a low oxygen atmos-
phere. In addition to HIF-1, a constitutive DNA binding
activity also specifically binds the HIFI probe. Here we
report that CRE and AP1 oligonucleotides efficiently
competed for binding of the HIF1 probe to this
constitutive factor, whereas HIF-1 activity itself
remained unaffected. Monoclonal antibodies raised
against the CRE binding factors ATF-1 and CREB-1
supershifted the constitutive factor, while Jun and Fos
family members, which constitute the AP-1 factor, were
immunologically undetectable. Recombinant ATF-1
and CREB-1 proteins bound HIF1 probes either as
homodimers or as heterodimers, indicating a new
binding specificity for ATF-1/CREB-1. Finally, reporter
gene assays in HeLa cells treated with either a cAMP
analogue or a phorbol ester suggest that the PKA, but
not the PKC signalling pathway is involved in oxygen
sensing.
INTRODUCTION
Oxygen tension was discovered as a regulator of mammalian
gene expression when it became evident that the increase in blood
erythropoietin (EPO) observed in anaemic individuals was due to
transcriptional activation of the EPO gene. EPO is secreted
primarily by the developing liver and adult kidney in response to
hypoxia and leads to enhanced erythropoiesis by inhibiting
apoptosis of erythroid precursor cells (reviewed in 1,2). The
resulting augmented erythrocyte number allows the organism to
adapt to reduced oxygen availability by increasing oxygen
transport capacity. Other hypoxia-inducible genes have since
been reported, including vascular endothelial growth factor
(VEGF; 3,4) and glycolytic enzymes (5-8). Using human
hepatoma cell lines (9) and several mouse models (10,11) a
hypoxia-inducible enhancer sequence has been localized in the 3'
flanking region of the EPO gene (12-15). Electrophoretic
mobility shift assays (EMSAs) revealed the presence of hypoxia-
inducible factor-I (HIF-1), which binds to a short DNA motif
corresponding to bases 3458-3465 (numbering according to 16)
within this enhancer sequence (17,18). Interestingly, HIF-1 DNA
binding activity, originally identified in EPO-producing human
hepatoma cells after hypoxic exposure, was also found in nuclear
extracts from a wide variety of non-EPO-producing cell lines,
indicating that hypoxic induction of HIF-1 is a general phenom-
enon in most if not all mammalian cells (19,20). This widespread
capacity for oxygen sensing followed by oxygen-dependent gene
expression has been further confirmed by introducing reporter
genes linked to the oxygen-dependent EPO enhancer into
different cell lines: increased reporter gene expression after
hypoxic exposure was observed in all transfected cells (19,21).
Functional binding sites for HIF-1 have also been identified in the
5' flanking region of the VEGF gene (3,4) and in the genes
encoding the ubiquitous glycolytic enzymes aldolase A (ALDA),
phosphoglycerate kinase 1 (PGK1), enolase 1 (ENO1), lactate
dehydrogenase A (LDHA) and phosphofructokinase L (PFKL)
(6,7). Analogously to the EPO enhancer, oligonucleotides
derived from these genes led to induced DNA binding patterns in
EMSAs using either purified HIF-1 protein or nuclear extracts
from a variety of hypoxically treated cells. These oligonucleo-
tides mediated oxygen-dependent reporter gene expression in
transient expression experiments (3,4,6,7), suggesting that HIF- 1
activity is not restricted to EPO gene regulation, but modulates
expression of several other genes as well.
Hypoxically induced binding of HIF- 1 requires phosphoryla-
tion and de novo transcription and translation (17,18). UV
cross-linking studies (19) and biochemical purification (22) have
revealed that HIF-1 binds DNA mainly as a heterodimeric
complex composed of two subunits termed HIF-la (Mr -120
kDa) and HIF-13 (Mr -91-94 kDa), both directly contacting
DNA (22). The recent cloning of the HIF-1 a and ,B subunits
revealed that both genes belong to the basic helix-loop-helix
(bHLH) family of transcription factors (23). While HIF-la is a
novel member of this family with greatest homology to the
Drosophila gene SIM, HIF-J1 is identical to the aryl hydrocarbon
receptor nuclear translocator (ARN7) gene (23). All of these
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MATERIALS AND METHODS
GENE LOCATION
hEPO
mEPO
hEPO
hPGKI
hPGK1
hPGK1
mPFKL
mLDHA
hENOl
hALDA
hVEGF
rVEGF
3 FS
3 FS
5'FS
5FS
5' UT
5'FS
IVS1
5 FS
5'FS
IVS4
5FS
sFS
+3065/+3082
+359/+376
-163/-180
-172/-189
+30/+13
+243/+226
+346/+361
-65/-48
-584/-601
+124/+141
-978/-961
+61/+78
SEQUENCE
gccc TACGTGCT gtctca
gccc TACGTGCT gcctcg
tgca GACGTGCG tgtggg
gtga GACGTGCG gcttcc
tgcc GACGTGCG ctccgg
ttgt CACGTCCT gcacga
ggcg TACGTGCT gcag
agcg GACGTGCG ggaacc
gggc CACGTGCG ccgcct
tctt CACGTGCG gggacc
tgca TACGTGGG ctccaa
tgca TACGTGGG cttcca
HIF-1 consensus binding site: BACGTSSK
b
HIF-1 consensus
HIF1
HIFlmt
HA20
HA18
H3'mt
AP-1 consensus
AP1
APImt
CRE
BACGTSSK
GCCCTACGTGCTGTCTCA
GCCCTAaaaGCITTCTCA
GCCCTACGTGCTGaCTCATC
CCTACGTGCTGaCTCATC
GCCCTACGTGCJTagtTCA
CTGASTMA
TTCCGGCTGACTCATCMGCG
TTCCGGCcaACTCATCMGCG
AGAGATTTGCCTGACGTCAGAGAGCTAG
Figure 1. HIF-1 consensus binding site and oligonucleotide probes used in
EMSA. (a) Alignment of DNA sequences reported to be bound by HIF- 1. The
conserved core HIF-4 binding site ACGT is in bold. (b) Alignment of the
oligonucleotide probes used in this study with the HIF-1 (bold) and AP-1
(underlined) consensus sequences (26). The CRE site differs from the AP-1
consensus only by insertion of a guanosine residue. Changes in the consensus
sequences are indicated by lower case letters. K = G or T; S = C or G; M = A
orC; B =CorGorT.
factors share a common region of homology 3' to the bHLH
domain termed PAS (PER, AhR/ARNT, SIM). Following
binding of aryl hydrocarbon ligands such as dioxin to the aryl
hydrocarbon receptor (AhR), ARNT heterodimerizes with AhR
to form a functionally active transcription factor activating genes
involved in xenobiotic detoxification.
Apart from the induced HIF-1 binding activity, EMSAs using
the EPO-derived HIF-1 binding oligonucleotide 5'-GCCCTAC-
GTGCTGTCTCA-3' show a prominent, specific constitutive
band and a weak non-specific band (6,17-19,22-24). Methyla-
tion interference studies revealed that HIF- 1 and the constitutive
activity bind an overlapping DNA sequence, but have distinct
methylation interference patterns (18). In contrast, the methyla-
tion interference pattern of the non-specific activity was indistin-
guishable from that of the free probe (18). UV cross-linking
experiments with the constitutive factor revealed a Mr of -30-40
kDa (19), suggesting that the constitutive activity is neither
identical to the HIF- Ic nor to the HIF- 1 P/ARNT subunits. In this
work we present evidence that activating transcription factor-I
(ATF- 1) and cAMP-responsive element binding-I (CREB-1) are
the major constitutive nuclear factors binding to the HIF- 1 DNA
recognition site.
Cell culture and hypoxic induction
The murine fibroblast cell line L929 (American Type Culture
Collection [ATCC] CCL- 1 NCTC clone 929) was a kind gift of
V.O'Donnall. L929 cells were cultured in Dulbecco's modified
Eagle's medium (DMEM, high glucose; Gibco-BRL) supplem-
ented with 10% heat-inactivated fetal calf serum (Boehringer-
Mannheim), 100 U/ml penicillin, 100 mg/ml streptomycin, lx
minimal essential medium non-essential amino acids, 2 mM
L-glutamine and 1 mM sodium pyruvate (all Gibco-BRL) in a
humidified atmosphere containing 5% CO2 at 37°C. Oxygen
tensions in the incubator (Forma Scientific model 3319) were
either 140 (20% 02 v/v, normoxia) or 7 mm Hg (1% 02 v/v,
hypoxia). Cells at a density of 2 x 105 cells/cm2 were subjected
to hypoxic induction for 4 h.
The human epitheloid carcinoma cell line HeLaS3 (ATCC
CCL-2.2), a subline of HeLa adapted to growth in suspension,
was cultured in Ham's F-12 medium (Gibco-BRL) supplemented
as described above. Hypoxic induction was achieved by incuba-
tion of HeLaS3 cells at a density of 1 x 107 cells/ml in a IL 237
tonometer (Instrumentation Laboratory) under continuous
stirring for 4 h at 37°C using gas mixtures of either 20% 02,5%
CO2 and 75% N2 (normoxia) or 1% 02, 5% CO2 and 94% N2
(hypoxia) at a flow rate of 500 ml/min.
Nuclear extract preparation
Nuclear extracts were prepared according to Semenza and Wang
(17). Briefly, 1 x 10 cells were washed twice with ice-cold
phosphate-buffered saline (PBS), harvested in 5 ml PBS and
centrifuged at 400 g for 5 min at 4°C. The cell pellet was washed
with 4 packed cell volumes of buffer A containing 10 mM
Tris-HCl, pH 7.8,1.5 mM MgCl2, 10mM KCl and left on ice for
10 min. Subsequently the cells were lysed by 10 strokes of a
Dounce homogenizer using a type B pestle and the nuclei were
pelleted at 4500 g for 5 min at 4°C, resuspended in 2 packed cell
volumes of buffer C (420 mM KCl, 20 mM Tris-HCl, pH 7.8,
1.5 mM MgCl2, 20% glycerol) and incubated at 4°C for 30 min
with gentle agitation. Immediately before use buffers A and C
were supplemented with 0.5 mM dithiothreitol (DTT), 0.4 mM
phenylmethylsulfonyl fluoride, 2 gg/ml each of leupeptin,
pepstatin and aprotinin and 1 mM Na3VO4 (all from Sigma). The
nuclear extract was centrifuged at 10 000 g for 30 min at 4°C and
the supernatant (0.5 ml) dialyzed twice against 500 ml buffer D
(20 mM Tris-HCl, pH 7.8, 100 mM KCI, 0.2 mM EDTA, 20%
glycerol) for 4 h at 4°C each. The dialysate was centrifuged at
10 000 g for 10 min at 4°C, aliquoted, frozen in liquid N2 and
stored at -80°C. Protein concentrations were determined using
the Bradford protein assay (BioRad) with bovine serum albumin
as standard.
Electrophoretic mobility shift assay (EMSA)
The sequences of the oligonucleotides used forEMSA are shown
in Figure 1. AP1 oligonucleotides were purchased from Promega
and the CRE oligonucleotide was from Santa Cruz
Biotechnology. Other oligonucleotides were synthesized by
Microsynth (Balgach, Switzerland). All oligonucleotides were
gel purified on 10% polyacrylamide gels prior to 5'-end-labeling
of the sense strand with [y-32P]ATP (NEN-DuPont) using T4
polynucleotide kinase (Fermentas). Unincorporated nucleotides
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Figure 2. Constitutive and hypoxia-inducible factors bind to the HIF-1 DNA recognition site, but only the constitutive factor binds to the AP-I site. (a) EMSA was
performed using an end-labeled HIFI oligonucleotide probe. Unlabeled HIFI competitor was added at 5- to 500-fold molar excess. (b) AP- I binding factors bound
to the API probe migrate to the same position as the constitutive factor bound to the HIFI probe. API competitor oligonucleotides were added at 1- to 100-fold molar
excess. (c) Mutant API oligonucleotides (APlmt) compete only marginally with the HIFI probe for binding of the constitutive factor. Mouse fibroblast L929 cells
were cultured under either normoxic (-) or hypoxic (+) conditions (see Materials and Methods). For oligonucleotide sequences see Figure I b.
were removed by gel filtration over Bio-Gel P60 (fine) columns
(BioRad). Labeled sense strands were annealed to a 2-fold molar
excess of unlabeled antisense strands. DNA-protein binding
reactions were carried out for 20 min at 4°C in a total volume of
20 gl containing 4-5 jg nuclear extract, 0.1-0.3 jg sonicated
denatured calf thymus DNA (Sigma) and 1 x 104 c.p.m.
oligonucleotide probe in 10 mM Tris-HCl, pH 7.5, 50 mM KCl,
50 mM NaCl, 1 mM MgCl2, 1 mM EDTA, 5 mM DTT, 5%
glycerol and run on 4% non-denaturating polyacrylamide gels.
Electrophoresis was performed at 200 V in TBE buffer (89 mM
Tris, 89mM boric acid, 5 mM EDTA) at4C and dried gels were
autoradiographed.
For competition experiments a 1- to 500-fold molar excess of
unlabeled annealed oligonucleotides were added to the binding
reaction mixtures prior to addition of the labeled probes. For
supershift analysis 1 jig antibody was added to the completed
EMSA reaction mixtures and incubated for 2 h at 4°C prior to
loading. All antibodies were obtained from Santa Cruz Biotech-
nology: D (anti-c-Jun, anti-Jun B and anti-Jun D) rabbit
polyclonal IgG; K-25 (anti-c-Fos, anti-Fos B, anti-Fra-I and
anti-Fra-2) rabbit polyclonal IgG; C41-5.1 (anti-ATF-i) mouse
monoclonal antibody (mAb) IgA; 25C lOG (anti-ATF-1, cross-re-
active with CREB-1 and CREM-1) mouse mAb IgGI; 24H4B
(anti-CREB-1) mouse mAb IgG. A polyhistidine-tagged re-
combinant ATF-I protein corresponding to amino acids 39-371
(34 kDa), purified by Ni2+ affinity column chromatography to
>95% homogeneity, and a truncated 10-14 kDa recombinant
CREB-1 (>95% pure), corresponding to amino acids 254-327
(DNA binding and dimerization domains), were both purchased
from Santa Cruz Biotechnology. Recombinant proteins were
pre-incubated for 5 min at 37°C with 5 jg bovine serum albumin
and calfthymus DNA in binding buffer as described above. After
adding labeled oligonucleotide probes the reaction mixtures were
incubated for 5 min at 37°C and 10 min at 4°C and analyzed by
EMSA.
Transient transfections and reporter gene assays
Luciferase reporter gene constructs were obtained by inserting
the oligonucleotides HIFI and HIFImt (Fig. Ib) into the BamHI
site 3' to the luciferase gene present in the pGL3Promoter plasmid
(Promega), which contains a heterologous SV40 promoter. Copy
number and orientation of the oligonucleotides were determined
by single-stranded DNA sequencing using RVprimer4 (Prome-
ga). HeLa cells (1 x 107 in 350 jl medium without fetal calf
serum) were transiently transfected with 25 jg DNA. Following
electroporation at 250 V and 960 jF (Gene Pulser, BioRad) the
cells were split in eight 10 cm2 tissue culture dishes (Falcon),
1 mM 8-bromo-cAMP (8Br-cAMP; Sigma) or 1 jM phor-
bol-12,13-dibutyrate (PDBu; Sigma) was added where indicated
and incubation was performed for 32 h at 20% or 1% 02. After
washing twice with PBS the cells were lysed in reporter lysis
buffer (Promega) and luciferase activity was determined accord-
ing to the manufacturer's instructions (Promega). Luminescence
was measured in a Biocounter M1500 luminometer (Lumac).
RESULTS
Constitutive and hypoxia-inducible factors bind to the
HIF-1 DNA recognition site
An alignment of all DNA sequence motifs known so far to be
bound by HIF-I revealed the tentative consensus binding site
BACGTSSK, with the core ACGT being conserved in all genes
(Fig. la). In an attempt to investigate the complex pattern of
proteins binding to the HIF-I sequence we analyzed nuclear
extracts derived from subconfluent cultures of normoxic (20%
02) or hypoxic (4 h at 1% 02) mouse L929 fibroblast cells by
EMSA. As shown in Figure 2 and as reported previously (17), the
18 bp HIFI oligonucleotide probe (Fig. lb) was bound by a
hypoxia-inducible, a constitutive and a non-specific factor
(nomenclature according to 17). Homologous competition
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Figure 3. The constitutive factor is not a member of the Jun and Fos families of transcription factors. (a) Factors bound to the API probe, but not the constitutive factor
bound to the HIFI probe, are supershifted by polyclonal antisera raised against Jun family members (aJUN) or Fos family members (aFOS). Oligonucleotides HA20
(b), HA 18 (c) and H3'mt (d) were used to determine the sequence exchanges necessary to allow Jun and Fos binding. For oligonucleotide sequences see Figure l b.
experiments using increasing molar excesses of unlabeled HIFI
oligonucleotides demonstrated that both HIF- 1 and the constitut-
ive activity specifically bound the HIFI probe, as shown in
Figure 2a. The intensity of the HIF-1 and constitutive bands
decreased in a similar fashion upon adding increasing amounts of
competitor, indicating that both factors bound DNA with
comparable affinities. Binding specificity was further confirmed
using a mutant HIF oligonucleotide termed HIFlmt (Fig. Ib; 17):
this mutant probe was not bound by either HIF-1 or the
constitutive factor and unlabeled HIFlmt did not compete for
binding of the wild-type HIFI probe by HIF-1 and the constitut-
ive activity (data not shown).
The constitutive but not the hypoxia-inducible binding
activity to the HIF-1 site is competed for by an AP1
oligonucleotide
A computer-assisted search in the tfsites.dat transcription factor
database of the GCG program package (25) was performed using
the 18 bp HIF-1 sequence (Fig. Ib) as query. Highest homology
was found to the 8 bp consensus activator protein-I (AP- 1) motif
(26) with one mismatch at position 4, where a thymidine was
replaced by an adenosine. As shown in Figure Ib, the first 2 bases
of the AP-1 site overlap the HIF- 1 consensus sequence.
Increasing amounts of unlabeled API oligonucleotides added to
L292 nuclear extracts specifically competed for binding of HIFI
oligonucleotide to the constitutive factor, whereas the hypoxi-
cally induced HIF- 1 binding activity remained unaffected (Fig.
2b). Specificity ofAP- 1 binding was demonstrated using a mutant
API oligonucleotide (APlmt, see Fig. lb and product datasheet,
Promega) which competed only marginally with wild-type API
oligonucleotides for binding to the constitutive factor (Fig. 2c). A
weak residual competition, however, might be attributed to some
residual AP-1 factor binding to the APlmt oligonucleotide, as
found by EMSA using labeled APlmt oligonucleotides (not
shown). Interestingly, gel migration of shifted protein-API
oligonucleotide complexes was comparable with the migration of
constitutive factor bound to the HIFI oligonucleotide (Fig. 2b),
indicating similar molecular weights for both proteins. These
results raised the question of whether the constitutive factor is
composed ofJun and Fos family members known to constitute the
AP- 1 factor as homodimers or hetereodimers.
Jun and Fos family members do not bind to the HIF-1
DNA recognition site
Commercially available polyclonal antibodies raised against Jun
and Fos family members were used to determine whether one or
several member(s) of these transcription factor families are
involved in constitutive binding to the HIF-l recognition site. Gel
supershift studies were performed using either anti-Jun anti-
bodies known to cross-react with c-Jun, JunB and JunD or
anti-Fos antibodies reacting with c-Fos, FosB, Fra-l and Fra-2
(see Materials and Methods). As shown in Figure 3a, no supershifts
were detected with either anti-Jun or anti-Fos antibodies. In
contrast, when the API oligonucleotide probe was used, binding
of these antibodies resulted in strong supershifts, indicating that
L929 cells expressed Jun and Fos family members and that these
factors bound to the API oligonucleotide probe independent of
whether the cells were grown under hypoxia or normoxia. These
observations imply that Jun and Fos family members do not
contribute to the constitutive HIFI oligonucleotide binding
activity.
To test the hypothesis that the single mismatch (A-+T) of the
AP-1 consensus sequence located within the HIFI oligonucleo-
tide (Fig. lb) was responsible for the lack of binding of Jun and
Fos proteins to this site we restored the wild-type AP- 1 motif in
oligonucleotides HA20 and HA18 (Fig. lb). Surprisingly, despite
the presence of a perfect AP- 1 consensus sequence in the HA20
and HA18 oligonucleotides, the intensity of the constitutive band
shown in Figure 3b and c did not increase to the level observed
with the API oligonucleotide (Fig. 3a). Furthermore, using the
HA20 oligonucleotide probe anti-Jun antibodies only marginally
shifted the DNA-protein complex, as seen in normoxic extracts,
whereas anti-Fos antibodies did not result in supershifts at all
(Fig. 3b). A mutant probe that lacked 2 bp at its 5'-end (HA18,
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Figure 4. The constitutive factor, but not HIF- 1, is immunologically related to ATF- 1. (a) The ATF- I -specific mAb C41-5.1 (CtATFI ) was used in EMSA with different
oligonucleotide probes containing the HIF- I consensus sequence, as well as with the CRE probe (see Fig. I b for oligonucleotide sequences). (b) A 100-fold molar
excess of unlabeled API or CRE oligonucleotides was used to block binding of labeled HIFI probe to the constitutive factor.
Fig. 1 b) was not bound by HIF- 1, while the constitutive binding
activity was still present (Fig. 3c). Interestingly, using the HA18
oligonucleotide probe both anti-Jun and anti-Fos antibodies
supershifted the constitutive band, irrespective of whether
normoxic or hypoxic (i.e. HIF-1 activity-containing) nuclear
extracts were used (Fig. 3c). These data demonstrate that a point
mutation restoring the wild-type AP- 1 site is not sufficient for Jun
and Fos binding. However, a double mutation restoring the AP- 1
site and preventing HIF- 1 binding (HA18, Fig. 1 b) allowed
replacement of the constitutive factor by Jun and Fos family
members. On the other hand, a mutant version of the HIFl
oligonucleotide abolishing the homology to the AP- 1 consensus
sequence (H3'mt, Fig. lb) did not influence the constitutive
binding activity (Fig. 3d) and addition of anti-Jun and anti-Fos
antibodies did not result in supershifts. In summary, these results
suggest that the HIF- 1 recognition sequence, which precedes (and
partially overlaps) the putative homology to the AP- 1 site, directs
a factor other than Jun and Fos family members to this site.
However, wild-type API oligonucleotides specifically and effi-
ciently competed with the HIFI probe for binding to this factor.
ATF-1 constitutively binds to the HIF-1 DNA
recognition site
Besides Jun and Fos family members, there are other transcription
factors known to bind to the AP- 1 or closely related motifs, among
them members of the ATF/CREB family, which bind to the
cAMP-responsive element (CRE). A mAb raised against ATF-l
(C41-5. 1; see Materials and Methods) almost completely super-
shifted the constitutive factor bound to the HIFI oligonucleotide, as
well as the factor bound to the CRE control oligonucleotide (Fig.
4a), indicating that the constitutive factor was immunologically
related to ATF- 1 and that it was composed of either ATF- 1
homodimers or heterodimers with one subunit being ATF- 1.
Next we investigated whether the various mutated HIF l
oligonucleotide probes shown in Figure lb were still capable of
binding ATF-1 by means of supershift experiments in EMSAs
using the anti-ATF- 1 mAb and L929 nuclear extracts. As shown
in Figure 4a, the point mutation restoring the wild-type AP- 1 site
within the HIF 1 oligonucleotide sequence (oligonucleotide
HA20) or even a 3 bp mutation that destroyed the homology to
the AP- 1 site (oligonucleotide H3'mt) did not prevent ATF- 1
from binding these oligonucleotides. In contrast, the HA 18
oligonucleotide probe, which was identical to HA20 except that
the first 2 bases were missing, was not bound by either HIF- 1 (see
also Fig. 3c) or, because no supershift was obtained with
anti-ATF- 1 mAb, by ATF-1 homodimers or heterodimers (Fig.
4a). Since the remaining constitutive DNA binding acitivity to the
HA 18 oligonucleotide probe was supershifted with anti-Jun and
anti-Fos antibodies (Fig. 3c), but not with anti-ATF- 1 antibodies
(Fig. 4a), it must be concluded that only the combination of both
mutations present in HAI 8, but not the point mutation in HA20
alone (transforming the AP- 1 homology to a wild-type AP- 1 site),
allowed efficient replacement of ATF- 1 by Jun and/or Fos
proteins.
Irrespective of whether HIFl or CRE oligonucleotide probes
were used, the intensities of the bands supershifted by the
anti-ATF- 1 mAb were comparable in nuclear extracts derived from
either normoxic or hypoxic cells. Since the supershifted constitut-
ive band partially overlapped the hypoxia-inducible HIF-1 band
(Fig. 4a), we could not conclude whether HIF- 1 bands were also
influenced by the anti-ATF- 1 mAb. To circumvent this problem
visualization of the constitutive binding activity was prevented by
addition of a 100-fold molar excess of unlabeled AP I (see Fig. 2b)
or CRE oligonucleotides prior to incubation with the antibody. As
shown in Figure 4b, both competitor oligonucleotides blocked
most of the constitutive activity binding the labeled HIFI probe
and the remaining HIF- 1 band was not shifted by the anti-ATF- 1
mAb, suggesting that ATF- 1 does not participate in HIF- 1
complex formation. Furthermore, no difference was observed in
competition experiments using increasing amounts of either API
oligonucleotides (as shown in Fig. 2b) or CRE oligonucleotides
(not shown), demonstrating that the constitutive factor had
comparable affinities for AP- 1 and CRE sites. In agreement with
"I III- -l..-l--..---.-...-.
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this, the anti-ATF- 1 mAb also supershifted a part of the proteins
bound to the API probe (not shown).
Detection of ATF-1 and CREB-1 binding to the HIF-1
site in nuclear extracts derived from HeLa cells
To confirm the results obtained with the murine fibroblast line
L929 we tested additional antibodies raised against
ATF-1/CREB-1 family members. We chose to investigate the
human epitheloid carcinoma cell line HeLa, which represents a
common model for hypoxic HIF- 1 induction and has been used
for biochemical purification of HIF- la and HIF- 1P/ARNT
subunits (22). HeLa cells were induced in a tonometer and
nuclear extracts were analyzed by EMSA. As shown in Figure 5a,
the previously used mouse anti-ATF- 1 mAb C41-5.1 (xATF1),
known to be reactive with human, mouse and rat ATF- 1 (product
datasheet, Santa Cruz Biotechnology), supershifted the constitut-
ive DNA binding activity of HeLa nuclear extracts similarly to
that of L929 cells. Two commercially available mAbs, both
human-specific, also supershifted the constitutive factor (Fig.
Sb): the mAb 2510G, termed cx(A/C) in Figure 5b, was raised
against human ATF- 1, but is cross-reactive with the related
factors CREB-1 and CREM-1; the mAb 24H4B (axCREB-1) was
raised against human CREB- 1 and is not cross-reactive with other
members of the ATF/CREB family. However, the extent to which
the three mAbs supershifted the constitutive band was clearly
different; while the anti-ATF- 1 mAb C41-5.1 and the anti-
ATF-1/CREB-1/CREM-1 mAb 25 lOG both resulted in an almost
complete supershift, the anti-CREB- 1 mAb 24H4B only partially
supershifted the constitutive band (Fig. Sb). Since the same
pattern was observed with CRE oligonucleotide probes, we
conclude that these results reflect the expression levels of the two
proteins, suggesting that in HeLa cells ATF- 1 represents the main
DNA binding activity of the ATF/CREB family. Similar observa-
tions have been reported by Hurst et al. (27,28). The stronger
band obtained with CRE probes compared with HIFI probes
might be explained by either a higher affinity of ATF- 1 for the
consensus CRE site or by binding of additional ATF/CREB
family members which cannot bind to the HIF-1 sequence. The
higher intensity of the constitutive band in hypoxic compared
with normoxic HeLa extracts (Fig. Sb) was due to unequal protein
loading and was not observed using other HeLa extracts, such as
those in Figure 5a. Interestingly, increased bound probe led to
decreased non-specific band intensity, suggesting different affi-
nities between the constitutive and non-specific factors for the
oligonucleotide probes.
Recombinant ATF-1 and CREB-1 bind to the HIF-1
DNA recognition site
To determine whether ATF-1 and CREB-1 are equally able to
bind to the HIF-1 site and, if so, to find out whether homodimers
or heterodimers preferentially bind the HIFI oligonucleotide
probe we performed EMSAs using commercially available
recombinant ATF- 1 (amino acids 39-371) and a truncated form
of CREB-1 (amino acids 254-327, corresponding to the DNA
binding and dimerization domains), thus allowing easy separ-
ation of both proteins on a gel. As shown in Figure 6, at least with
recombinant proteins, the HIFI oligonucleotide probe was bound
more strongly by CREB- 1 and ATF- 1/CREB-1 heterodimers than
by ATF- 1 alone. A mutation in the HIF-1 motif (oligonucleotide
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Figure 5. ATF-1 and CREB-1 bind to the HIF-1 site. (a) The anti-ATF-1 mAb
C41-5.1 (aATF1) was used in EMSA with mouse L929 and human HeLa
nuclear extracts. (b) The mAb 25C1OG, raised against human ATF-1 and
cross-reactive with CREB-1 and CREM-1 (otA/C) and the mAb 24H4B,
specific for human CREB-1 (aCREB 1), were used together with HIFI or CRE
probes.
HIFlmt, see Fig. Ib) completely impeded binding of ATF-1 and
CREB-1, whereas the two mutations lying 3' to the HIF-1 site
(oligonucleotides HA20 and H3'mt, see Fig. Ib) did not
significantly alter the binding pattern. The probe HA18, lacking
the two 5' bases present in HA20 (Fig. Ib), again did not allow
ATF-1 binding, as was the case with nuclear extracts (Fig. 4a). In
striking contrast, HA18 was still bound to CREB-1, indicating
that ATF- 1, but not CREB- 1, binding is strictly dependent on the
presence of these two bases at the 5'-end. On the other hand, the
CRE oligonucleotide probe bound to ATF- 1 and CREB- 1
homodimers with comparable affinities and pre-mixing of ATF- 1
and CREB- 1 in a 1:1 molar ratio resulted in an almost
stochiometric distribution of homo- and heterodimer binding.
A cAMP agonist enhances hypoxic induction of
reporter gene expression
Binding of ATF-1/CREB-1 to the HIF-1 site suggests that the
HIF-1 enhancer is cAMP responsive. To test this hypothesis we
constructed luciferase plasmids containing a heterologous SV40
promoter and one or three copies of the 18 bp oligonucleotides
HIFI or HIFlmt (Fig. lb) inserted 3' of the luciferase gene
(Fig. 7). Following transfection into HeLa cells either the PKA
activator 8Br-cAMP or the PKC activator PDBu was added and
the cells were incubated under normoxia or hypoxia. The
resulting luciferase expression was normalized to the untreated
normoxic control (Fig. 7). In HeLa cells transfected with a plasmid
containing three copies of the HIFI oligonucleotide hypoxia
significantly increased luciferase expression by 6.3-fold (P < 0.01,
n = 3, Student's t-test). The addition of 8Br-cAMP enhanced this
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insufficient to markedly enhance hypoxic induction of the
pGL3Promoter plasmid.
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Figure 6. Recombinant ATF-I and CREB-l bind the HIFI probe as
homodimers or as heterodimers. A full-length 34 kDa ATF- I protein (A) and
a truncated 10-14 kDa CREB-1 protein (C), containing the DNA binding and
dimerization domains, were used with the probes shown in Figure l b. Detection
of heterodimer formation was performed by premixing ATF-1 and CREB-
proteins in a 1:1 molar ratio (A/C).
hypoxic induction by 64% (P < 0.05), whilst PDBu had no effect.
8Br-cAMP also slightly induced normoxic luciferase expression,
but this effect was only found to be significant following
normalization to the untreated hypoxic values (P < 0.05).
Normalization to a co-transfected lacZ plasmid was not practi-
cable, since the P-galactosidase activity itself was induced by
8Br-cAMP (not shown). A luciferase construct containing three
copies of the mutant HIFlmt oligonucleotide, as well as
constructs containing one copy of either HIFI or HIFlmt, showed
no significant induction by either hypoxia or 8Br-cAMP. A slight
inducibility was observed in the pGL3Promoter vector itself,
suggesting that the SV40 promoter is weakly hypoxia responsive.
Thus one copy of the HIF-1 enhancer sequence seems to be
DISCUSSION
The discovery of a nuclear factor (HIF- 1) whose DNA binding
activity can be induced by low oxygen concentrations provided
the first step towards understanding the mechanisms of hypoxia-
regulated gene expression. That hypoxic induction is unique to
HIF-1 is supported by EMSAs, performed with a variety of
probes other than HIFl and using our L929 nuclear extracts,
which do not show any difference in factor binding between
hypoxic and normoxic cell culture conditions. The probes
contained binding sites for the following factors: AP- 1 (Jun and
Fos family members, Fig. 2); CRE-binding factors (ATF/CREB
family members, Fig. 4); AP-2, AP-3, Sp-1, MTF (not shown);
C/EBPI, NF-KB, STAT-1 and STAT-3 (V.Poli, personal com-
munication).
Characterization of the HIF- 1 DNA binding activity in EMSAs
revealed the presence of a constitutive activity which, in addition
to the hypoxia-inducible factor HIF- 1, binds to the HIFI
oligonucleotide probe. Based on the data presented in this work,
we found the following evidence that most if not all of this
constitutive factor is closely related or identical to the transcrip-
tion factors ATF- 1 and CREB- 1: (i) CRE oligonucleotides
specifically competed for HIFl oligonucleotide probe binding to
the constitutive factor, whereas the inducible HIF-1 activity
remained unaffected; (ii) mAbs raised against ATF- 1 and
CREB- 1 supershifted most of the constitutive factor in nuclear
extracts derived from mouse and human cell lines, whereas the
HIF- 1 shift was not influenced; (iii) purified recombinant ATF- 1
and CREB-1 proteins bound HIFI oligonucleotide probes as
homo- or heterodimers.
Transcription factors of the ATF/CREB family were originally
defined by their specific binding to a palindromic sequence
(TGACGTCA), known as the cAMP-responsive element (CRE),
which has been found in many cAMP-inducible cellular genes
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Figure 7. The HIF-1 binding site is hypoxia and cAMP responsive. The oligonucleotides HIFI and HIFI mt (Fig. l b) were subcloned 3' of the luciferase reporter gene
driven by the SV40 promoter. Copy number and orientation are indicated. Reporter gene expression in HeLa cells treated with either the cAMP analogue 8Br-cAMP
or the phorbol ester PDBu under normoxic or hypoxic conditions is shown as a percentage of the respective untreated normoxic control (means ± SD of three
independent experiments).
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and in several viral promoters (reviewed in 29-31). All of these
proteins share a common basic DNA binding domain followed by
a leucine zipper dimerization domain. Among the increasing
number of ATF/CREB family members CREB-1 is the best
characterized factor. CREB-1 has been shown to be a target of
cAMP-inducible PKA-mediated phosphorylation, which is
required for transcriptional activator function. Binding of nuclear
factors to the CRE site, however, is usually not induced by
PKA-dependent phosphorylation and requires leucine zipper-
mediated dimerization. Homodimerization and heterodimeriz-
ation of CREB-1 with other members of the ATF/CREB family
and even with members of the Jun/Fos family have been reported
(32). In contrast to CREB-1, the function of ATF-1 is poorly
understood. It is known that multiple phosphorylation of ATF- 1
leads to a dramatic change in conformation which affects the
stability of DNA binding (33). Compared with CREB-1,
PKA-dependent phosphorylation of ATF- 1 does not seem to be
a major inducer of transcriptional activator function (28). ATF-1
is most homologous to CREB-1 and is known to form hetero-
dimers with CREB-1. With regard to the unusual DNA recogni-
tion specificity of ATF-1/CREB-1 bound to the HIF-1 site (see
below), we cannot rule out the possibility that ATF-1 binds the
HIFI probe as an heterodimer together with a yet to be identified
factor. Indeed, altered DNA recognition specificity after differen-
tial heterodimer formation has been reported for other ATF/
CREB family members (30,32).
The relative molecular weight (Mr) of ATF-1 has been shown
to be dependent on its phosphorylation status (33) varying
between -35 and 40 kDa (28). This is in agreement with UV
cross-linking experiments of constitutive factor binding to the
HIFI oligonucleotide, which revealed a Mr of -30-40 kDa (19).
The protein-DNA contact sites of the constitutive factor have
been analyzed by methylation interference and were found to be
closely related to the HIF-1 contact sites (18). This is not
consistent with the result of the computer search, which revealed
a putative AP-1/CRE motif located 3' to the HIF-1 site (model a
in Fig. 8). Based on the observations presented in this study, we
conclude that the ATF- 1 binding site does indeed match the HIF- 1
DNA recognition site: (i) the mutant oligonucleotide HIFlmt (see
Fig. Ib) was not bound by either HIF- 1 or the constitutive factor
and HIFlmt did not compete with the wild-type HIFI probe for
binding to the constitutive factor; (ii) a mutation in the putative
AP-1/CRE site located 3' to the HIF-1 motif (probe H3'mt) did
not abolish constitutive factor binding; (iii) generation ofa perfect
homology to the AP-1 consensus located 3' to the HIF-1 motif
(probe HA20) only allowed efficient Jun and Fos binding when
in addition to this mutation the first twoS' bases were absent (probe
HA18), which abolished HIF-1 and constitutive factor (ATF-1, but
not CREB-1) binding. Thus both HIF-la/HIF-1 3(ARNT) hetero-
dimers and ATF- 1/CREB-1 homodimers and heterodimers bind
to the HIF- 1 DNA recognition site in vitro, as shown by EMSAs.
A re-inspection of the homology comparison between the CRE
motif and the HIFI oligonucleotide (model a in Fig. 8) revealed
another possible match in which the core CRE motif overlaps the
core HIF-1 motif ACGT (model b in Fig. 8), which is conserved
in all HIF-1 binding sites found so far (Fig. la). Despite a reduced
overall homology, model b is more consistent with our data than
model a. Based on the result obtained with the HA18 probe (Fig.
lb), which efficiently binds CREB-1 homodimers, but only
marginally ATF-I homodimers or ATF-1/CREB-1 heterodimers
Model a
HIF-1 consensus
HIF1 probe
AP-1 consensus
CRE consensus
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HIF-1 consensus
HIF1 probe
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BACGTSSK11|1111
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III III
III III
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11111111
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Figure 8. Two possible homologies between the HIFI oligonucleotide probe
and AP- 1/CRE consensus motifs. For AP-I and HIF- 1 consensus sequences see
Figure 1. The palindromic consensus CRE sequence is from Lalli and
Sassone-Corsi (31). K = G or T; S = C or G; M = A or C; B = C or G or T.
(Fig. 6), one must conclude that ATF-I binding is dependent on the
presence of the two 5' bases of the HIFI probe. Thus ATF-1 most
probably occupies the 5' half-site when bound to DNA as a
heterodimer.
It remains an open question whether HIF- 1 and the constitutive
factor (ATF-1/CREB-1) bind to the HIF-1 DNA recognition site
simultaneously in vivo or whether following hypoxic stimulation
ATF- 1/CREB- 1 is replaced by HIF- 1. However, based on
methylation interference assays revealing that HIF-1 and the
constitutive factor contact the same guanosine residues (18), we
favor the model that following hypoxic induction
ATF-1/CREB-1 is replaced by HIF- 1; even though in vitro ATF-I
and CREB-1 are still capable ofbinding to the HIFI probe, which
was offered in excess. In this context it is interesting to note that
while protein kinase A-dependent phosphorylation ofATF- 1 only
marginally affects transcriptional activator function (28), phos-
phorylation-dependent conformational changes of ATF-1 are
known to contribute to the instability of the interaction with DNA
(33). It is therefore tempting to speculate that such a conforma-
tional change could allow replacement of ATF-1 by HIF-1
following hypoxic stimulation.
Our finding that a CRE site overlaps the hypoxia-inducible
cis-acting element raised the question whether the cAMP signal
transduction pathway is involved in the oxygen sensing mechan-
ism. Functional reporter gene studies using the PKA activator
8Br-cAMP demonstrated that under hypoxic conditions the
HIF-1 site was cAMP responsive. This result is in line with our
previous report showing that hypoxia induces activity of the
glycolytic enzyme LDH and also increases the cAMP content in
vascular smooth muscle cells (8). Furthermore, activators of
adenylate cyclase induced LDH activity, while inhibitors ofPKA
blocked hypoxia-inducible LDH up-regulation (8). Since func-
tional HIF- 1 cis-regulatory elements have also been localized in
the LDH gene (6,7), these results on LDH regulation support the
idea that cAMP-dependent phosphorylation of ATF- 1 might be a
crucial component of HIF-1-mediated hypoxia-inducible gene
expression in mammalian cells.
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